$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Total Assets
$1.19B
Quarterly · Period ending: · USD

RARE Total Assets
Latest reported$1.53Bperiod ending
Latest reported$1.53Bperiod ending
RARE FY Total Assets ($12.13M → $1.53B)
Annual total assets
High-resolution chart · PNG
What is total assets?
Total value of everything the company owns.
RARE total assets history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Assets (USD) |
|---|---|
| 1,532,000,000 | |
| 1,503,456,000 | |
| 1,491,013,000 | |
| 1,545,444,000 | |
| 1,522,397,000 | |
| 1,759,555,000 | |
| 1,135,496,000 | |
| 719,558,000 | |
| 490,753,000 | |
| 540,626,000 | |
| 559,569,000 | |
| 197,967,000 | |
| 59,649,000 | |
| 88,316,000 | |
| 12,129,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance